[ Home | Contents | Search | Post | Reply | Next | Previous | Up ]
From: McGoon
Date: 13 Nov 2005
Time: 04:28:33 -0000
Remote Name: 59.107.96.123
Mayo Rochester Cardiologist Michael McGoon had called a few days earlier to let me know that he was going to send me a manuscript with the potential to attract a lot of media attention. It was a series of case reports that concluded there may be an association between taking the weight-loss drugs fenfluramine-phentermine (fen-phen) and developing valvular heart disease. Dr. McGoon's colleague, Dr. Heidi Connolly, was the primary author of the manuscript. It was scheduled to be published in the New England Journal of Medicine in several weeks, so we had some time to plan our communication effort.
Article continue:
http://www.findarticles.com/p/articles/mi_m4422/is_n5_v15/ai_20873103 49. Health http://www.2e2.info/search/health 50. Phentermine http://www.2e2.info/search/phentermine 51. Diabetes http://www.2e2.info/search/diabetes 52. Viagra http://www.2e2.info/search/viagra 53. Lipitor http://www.2e2.info/search/lipitor 54. Health Insurance http://www.2e2.info/search/health-insurance 55. HGH http://www.2e2.info/search/hgh 56. Online Pharmacy http://www.2e2.info/search/online-pharmacy 57. Flonase http://www.2e2.info/search/flonase 58. Diet http://www.2e2.info/search/diet 59. Celebrex http://www.2e2.info/search/celebrex